Member Info for TruthCaller

Either that or he reckons its a dog.

Who knows whats going on here, it appears NFX aint got a clue too.

A postive clear RNS from whoever is in charge would be much appreciated by shareholders right now.

it is now the 1st of July.

NFX really needs to get its act together.

Some clear direction here is urgently required.

Riddler

Spot on....typing the exact same words ...you beat me to it.

This BF fella has no holding but is obsessed with MTFB since May, i say again since.....May.

gla holders.

Interesting his job done perhaps? Fireworks Monday?

dyor and gla .

Some chunky buys beeing thrown in today!

News inbound?

dyor and gla.

Agree.

Strong buy.

dyor and gla.

Yes, agree, started buying here too.

dyor and gla.

yes....looks like Mr Thomas Anderson is after more shares...

dyor and gla

Another %700 rise again today?

dyor and gla.

https://uk.reuters.com/article/brief-nuformix-plc-announces-agreement-w/brief-nuformix-plc-announces-agreement-with-vistagen-idUKFWN2D903L

https://www.proactiveinvestors.co.uk/companies/news/920486/nuformix-inks-development-agreement-business-remains-resilient-during-lockdown-920486.html

Aye agree.

Some cracking info and news in that update imho.

dyor and gla.

In

gla

hamiltonbro....well put. I have been adding for the past few weeks here....not easy to buy at times...goes to NT a lot.

gl

Also in TRX looking good atm...imho

dyor and gla

Another top up.

gla

Theres Gold in them hills!

holding up well today it would appear....some strengh and a tight spread.

gla

Agree, some great potential here, very undervalued and under the radar it seems, i have been topping up this week in the lows.

dyor and gla

4th May RNS Directorate Changes

Christopher (Chris) Wardhaugh

Chris is currently a Non-Executive Director of Altair Medical Limited and Lamellar Biomedical Limited, both based in Scotland. Chris is also Chief Business Officer of MGB Biopharma Limited, a clinical-stage antibiotic company and is the founder of Sercader Limited, a life sciences advisory firm.


Chris has over 28 years' experience in life sciences with international experience across large and small companies, all stages of development and commercialisation of companies including preclinical and clinical development, product launches throughout Europe and the United States, M&A and corporate development. Chris has an impressive transaction history working on deals including product licensing, IPOs and both Angel and VC investments.

Commenting, Bruce Williams, Chairman of Motif Bio, said: "We welcome Chris to the Board as we focus on sourcing an appropriate reverse takeover candidate for Motif Bio. We believe that the Company will benefit from Chris's breadth of knowledge and transactional experience and we will provide shareholders with further updates in due course."

Dont feed the Trolls....blue by eop...imho...dyor and gla.